Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Prophase Labs Inc PRPH

Healthcare Medical Care
ProPhase Labs, Inc. is a biopharma, genomics, and diagnostics company. The Company provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its... see more

Recent & Breaking News (NDAQ:PRPH)

Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir

GlobeNewswire June 28, 2022

ProPhase Labs Announces Significant Laboratory Expansion

GlobeNewswire June 13, 2022

ProPhase Labs to Present at the H.C. Wainwright 2022 Global Investment Conference

GlobeNewswire May 18, 2022

ProPhase Labs Announces Record First Quarter 2022 Financial Results

GlobeNewswire May 13, 2022

ProPhase Labs to Present at the Spring Into Action - Best Ideas Virtual Investor Conference

GlobeNewswire May 11, 2022

ProPhase Labs Announces Appointment of Bill White as Chief Financial Officer

GlobeNewswire May 10, 2022

ProPhase Labs to Host First Quarter 2022 Financial Results Conference Call on Friday, May 13, 2022 at 11:00 a.m. Eastern Time

GlobeNewswire May 6, 2022

ProPhase Labs to Present at the Planet MicroCap Showcase 2022 on Wednesday, May 4, 2022

GlobeNewswire April 27, 2022

ProPhase Labs Announces Record Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021

GlobeNewswire March 30, 2022

ProPhase Labs to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Wednesday, March 30, 2022 at 11:00 a.m. Eastern Time

GlobeNewswire March 24, 2022

ProPhase Labs Announces Special Cash Dividend

GlobeNewswire February 16, 2022

ProPhase Labs to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Conference

GlobeNewswire February 3, 2022

ProPhase Labs Announces Record COVID-19 Testing in Q4 2021

GlobeNewswire January 13, 2022

ProPhase Labs to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference

GlobeNewswire January 5, 2022

ProPhase Labs Continues to Build Strong Leadership with Key Promotions and Additions to Management Team

GlobeNewswire December 16, 2021

PROPHASE LABS, INC. ANNOUNCES INDUCEMENT AWARD UNDER NASDAQ LISTING RULE 5635(C)(4) 

GlobeNewswire November 23, 2021

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2021

GlobeNewswire November 12, 2021

ProPhase Labs to Present at the Q4 Investor Summit Conference

GlobeNewswire November 10, 2021

ProPhase Labs to Host Third Quarter 2021 Financial Results Conference Call on Friday, November 12, 2021 at 11:00 a.m. Eastern Time

GlobeNewswire November 5, 2021

ProPhase Labs Provides Business Update

GlobeNewswire October 13, 2021